Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-11-12 |
2024-09 |
0 |
N/A |
N/A |
N/A |
2024-08-19 |
2024-06 |
0 |
-4.19 |
N/A |
N/A |
2024-05-20 |
2024-03 |
-3.33 |
-9.14 |
-5.81 |
-174.47% |
2024-04-02 |
2023-12 |
-17.14 |
N/A |
N/A |
N/A |
2023-11-14 |
2023-09 |
-5.99 |
-48.77 |
-42.78 |
-714.19% |
2023-08-14 |
2023-06 |
-115.6 |
-36.8 |
78.8 |
68.17% |
Date |
Firm |
Action |
From |
To |
2023-09-05 |
HC Wainwright & Co. |
Upgrade |
Buy |
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2022-07-18 |
ALBANNA AMRO A |
Officer |
1.00 |
Purchase |
2021-06-03 |
ALBANNA ROWENA |
Chief Operating Officer |
0.00 |
Stock Award(Grant) |
2023-09-06 |
BNP PARIBAS SECURITIES CORPORATION NORTH AMERICA |
Unknown |
22.34K |
Sale |
2021-05-25 |
FARLEY THOMAS J |
Officer |
2.50K |
Purchase |
2020-07-21 |
KIAIE NAMVAR |
Director |
2.22K |
Conversion of Exercise of derivative security |
2021-06-03 |
PANKOVCIN CORINNE D |
Chief Financial Officer |
169.22K |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Sabby Management, LLC |
14.74K |
265.30K |
6.17% |
2023-06-29 |
Vanguard Group Inc |
1.16K |
20.92K |
0.49% |
2023-09-29 |
IFP Advisors, Inc |
1.08K |
13.53K |
0.45% |
2023-06-29 |
State Street Corporation |
948.00 |
17.06K |
0.40% |
2023-06-29 |
Natixis |
250.00 |
4.50K |
0.10% |
2023-06-29 |
Tower Research Capital LLC (TRC) |
246.00 |
4.43K |
0.10% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Extended Market Index Fund |
1.16K |
20.92K |
0.49% |
2023-05-30 |
Fidelity Extended Market Index Fund |
39.00 |
951.00 |
0.02% |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
44.00 |
1.07K |
0.02% |
2023-05-30 |
Fidelity Series Total Market Index Fund |
18.00 |
439.00 |
0.01% |
Split |
Date |
1 : 40 |
2023-08-18 |
1 : 50 |
2022-09-14 |
1 : 50 |
2022-09-12 |